Organisations can apply for a share of £6 million, inclusive of VAT, to develop or repurpose platform technologies. These technologies can be used as clinical tools to enable the bio-marker guided development of transformative dementia therapies.
- Competition opens: Monday 24 July 2023
- Competition closes: Monday 4 September 2023 11:00am
This is a Small Business Research Initiative (SBRI) competition funded by Innovate UK.
The aim of the competition is to accelerate innovations in dementia biomarker detection to transform clinical trials and precision therapies.
This will be achieved by the development of or repurposing of technologies that will enable the robust detection of emerging dementia clinical biomarkers. The application of innovations in wet biomarkers, data, and tools and services, will feed into and support the aims of the UK government’s Dame Barbara Windsor dementia mission.
This is a single-phase competition.
In applying to this competition you are entering into a competitive process.
Any adoption and implementation of a solution from this competition would be subject to a separate, possibly competitive, procurement exercise. This competition does not cover the purchase of any solution.
This competition closes at 11am UK time on the date of the deadline.